Ignite Creation Date:
2024-05-06 @ 10:41 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03326674
Status:
TERMINATED
Last Update Posted:
2021-07-30
First Post:
2017-10-13
Brief Title:
Tesetaxel Plus Reduced Dose of Capecitabine vs Capecitabine in HER2 Negative HR Positive LAMBC
Sponsor:
Organization:
Odonate Therapeutics Inc